Regulatory Approvals

FDA approves ILUMYA for adults with active psoriatic arthritis – News

By

Regulatory Approvals — FDA approves ILUMYA for adults with active psoriatic arthritis  News-Medical

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 31, 2026.

By

Related Post

Regulatory Approvals

FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis

Regulatory Approvals

US FDA approves Inovio’s treatment for rare throat disease; shares surge

Regulatory Approvals

FDA Approves Tildrakizumab for Psoriatic Arthritis in Adults

Financial News For All

Regulation

Appeals court reverses rejection of damages award against NFL in Sunday Ticket class action

Regulation

SEC Issues Exemptive Relief from Treasury Clearing Requirements for Certain Inter-Affiliate and Non-U.S. Repo Transactions

Regulation

Trump EPA Brings Closure to 20-Year-Old Agreement, Ending Decades Long Uncertainty For Thousands of American Farms

Regulation

New Jersey Agricultural Society Joins EPA’s Feed It Onward Program to Prevent Food Waste